Zynext Ventures is the venture capital arm of Zydus Lifesciences, a global pharmaceutical company with a market cap of > $8 Billion. Zydus Lifesciences has strong presence in US and Europe, with US contributing ~50% of the annual revenues.
Zynext Ventures is a new-age Venture Capital firm investing in seed and early-stage disruptive healthcare technologies.
We were founded with a mission to identify and nurture the next-generation of healthcare innovators who are disrupting the status quo and developing life-changing solutions.